Thyroid hormone and the cardiovascular system.

Thyroid hormone is an important regulator of cardiac function and cardiovascular hemodynamics. Triiodothyronine, (T(3)), the physiologically active form of thyroid hormone, binds to nuclear receptor proteins and mediates the expression of several important cardiac genes, inducing transcription of the positively regulated genes including alpha-myosin heavy chain (MHC) and the sarcoplasmic reticulum calcium ATPase. Negatively regulated genes include beta-MHC and phospholamban, which are down regulated in the presence of normal serum levels of thyroid hormone. T(3) mediated effects on the systemic vasculature include relaxation of vascular smooth muscle resulting in decreased arterial resistance and diastolic blood pressure. In hyperthyroidism, cardiac contractility and cardiac output are enhanced and systemic vascular resistance is decreased, while in hypothyroidism, the opposite is true. Patients with subclinical hypothyroidism manifest many of the same cardiovascular changes, but to a lesser degree than that which occurs in overt hypothyroidism. Cardiac disease states are sometimes associated with the low T(3) syndrome. The phenotype of the failing heart resembles that of the hypothyroid heart, both in cardiac physiology and in gene expression. Changes in serum T(3) levels in patients with chronic congestive heart failure are caused by alterations in thyroid hormone metabolism suggesting that patients may benefit from T(3) replacement in this setting.

[1]  C. Glass,et al.  Coactivator and corepressor complexes in nuclear receptor function. , 1999, Current opinion in genetics & development.

[2]  F I Gilbert,et al.  Graves' disease. Influence of age on clinical findings. , 1988, Archives of internal medicine.

[3]  D. Cooper,et al.  L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. , 1984, Annals of internal medicine.

[4]  R. D'Agostino,et al.  Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. , 1994, The New England journal of medicine.

[5]  L. Braverman,et al.  The effects of amiodarone on the thyroid. , 2001, Endocrine reviews.

[6]  Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. , 1999, The Journal of clinical endocrinology and metabolism.

[7]  G S Levey,et al.  Treatment of Hyperthyroid Disease , 1994, Annals of Internal Medicine.

[8]  A. Toft,et al.  Left ventricular performance in subclinical hypothyroidism. , 1985, The Quarterly journal of medicine.

[9]  S. Nekolla,et al.  Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging. , 2000, The Journal of clinical endocrinology and metabolism.

[10]  P. Agostoni,et al.  Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy. , 1996, The American journal of medicine.

[11]  M. Lazar.  Thyroid hormone receptors: multiple forms, multiple possibilities. , 1993, Endocrine reviews.

[12]  S. Homma,et al.  A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. , 1999, The Journal of thoracic and cardiovascular surgery.

[13]  S. Padayatty.  Concerning minimal cardiac effects in asymptomatic athyreotic patients treated with thyrotropin-suppressive doses of L-thyroxine. , 1998, The Journal of clinical endocrinology and metabolism.

[14]  I. Klein,et al.  Thyroid hormone therapy in cardiovascular disease. , 1996, Progress in cardiovascular diseases.

[15]  F. Epstein,et al.  The molecular basis of thyroid hormone action. , 1994, The New England journal of medicine.

[16]  K. Ellenbogen,et al.  The management of atrial fibrillation. , 1996, The American journal of medicine.

[17]  F. B. Davis,et al.  Acute cellular actions of thyroid hormone and myocardial function. , 1993, The Annals of thoracic surgery.

[18]  E. Kranias,et al.  Phospholamban: a prominent regulator of myocardial contractility. , 1996, Circulation research.

[19]  S. Houser,et al.  The sarcoplasmic reticulum and the Na+/Ca2+ exchanger both contribute to the Ca2+ transient of failing human ventricular myocytes. , 1999, Circulation research.

[20]  P. Nicod,et al.  The Thyroid and the Heart , 1993, Circulation.

[21]  E. Morkin.  Regulation of Myosin Heavy Chain Genes in the Heart , 1993, Circulation.

[22]  A. Toft,et al.  Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation. , 1979, The American journal of cardiology.

[23]  P. Foldes,et al.  Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventricular dysfunction by maximization of metabolic and mechanical support. , 1997, The Journal of thoracic and cardiovascular surgery.

[24]  P. Allenby,et al.  Congestive heart failure and sudden death in a young woman with thyrotoxicosis. , 1988, The Western journal of medicine.

[25]  S. Olsson,et al.  Long QT interval and ventricular tachycardia of "torsade de pointe" type in hypothyroidism. , 2009, Acta medica Scandinavica.

[26]  J. Izzo,et al.  Ca2+-induced Ca2+ release involved in positive inotropic effect mediated by CGRP in ventricular myocytes. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[27]  I. Klein,et al.  Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. , 1996, The Annals of thoracic surgery.

[28]  R. Segal,et al.  Thyrocardiac disease and its management with radioactive iodine I-131. , 1961, JAMA.

[29]  K. Hryniewicz,et al.  Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state. , 2002, Thyroid : official journal of the American Thyroid Association.

[30]  Mathew R. Williams,et al.  Thyroidectomy using local anesthesia in critically ill patients with amiodarone-induced thyrotoxicosis: a review and description of the technique. , 2002, Thyroid : official journal of the American Thyroid Association.

[31]  S. Mariotti,et al.  Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. , 2000, The Journal of clinical endocrinology and metabolism.

[32]  B. Weintraub,et al.  Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome". , 1991, The Annals of thoracic surgery.

[33]  A. Toft,et al.  Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy. , 1982, The New England journal of medicine.

[34]  B. Biondi,et al.  Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. , 2002, The Journal of clinical endocrinology and metabolism.

[35]  I. Klein,et al.  Thyroid hormone and the cardiovascular system. , 1990, The American journal of medicine.

[36]  É. Kiss,et al.  Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. , 1994, Circulation research.

[37]  I. Klein,et al.  Thyrotoxicosis and the heart. , 1998, Endocrinology and metabolism clinics of North America.

[38]  J S Child,et al.  Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. , 1998, The American journal of cardiology.

[39]  P. Petersen,et al.  Stroke in thyrotoxicosis with atrial fibrillation. , 1988, Stroke.

[40]  I. Klein,et al.  Usefulness of triiodothyronine (T3) treatment after surgery for complex congenital heart disease in infants and children. , 1999, The American journal of cardiology.

[41]  M. Lazar,et al.  Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone. , 1990, The Journal of clinical investigation.

[42]  I. Klein,et al.  Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. , 1991, The Journal of clinical endocrinology and metabolism.

[43]  I. Klein,et al.  Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac beta-adrenergic receptor responsiveness. , 2000, Metabolism: clinical and experimental.

[44]  H. Lindberg,et al.  Depressed thyroid function following paediatric cardiopulmonary bypass: association with interleukin-6 release? , 1996, Scandinavian journal of thoracic and cardiovascular surgery.

[45]  A. Pezzarossa,et al.  Power spectral analysis of heart rate in hyperthyroidism. , 1996, The Journal of clinical endocrinology and metabolism.

[46]  A. Hofman,et al.  Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study , 2000, Annals of Internal Medicine.

[47]  M. Luu,et al.  Altered thyroid hormone metabolism in advanced heart failure. , 1990, Journal of the American College of Cardiology.

[48]  T. Visser,et al.  Uptake of thyroid hormones in neonatal rat cardiac myocytes. , 1996, Endocrinology.

[49]  A. Samarel,et al.  Thyroid hormone effects on cardiac gene expression independent of cardiac growth and protein synthesis. , 1992, The American journal of physiology.

[50]  D. Iannone.  [The cardiovascular system in hypothyroidism]. , 1967, Il Policlinico. Sezione pratica.

[51]  W. Wiersinga.  Amiodarone and the thyroid , 1997 .

[52]  I. Klein,et al.  Acute effects of thyroid hormone on vascular smooth muscle. , 1996, Thyroid : official journal of the American Thyroid Association.

[53]  J. Franklyn,et al.  Thyroid status in patients after acute myocardial infarction. , 1984, Clinical science.

[54]  J. Patterson,et al.  MECHANISM OF CERTAIN ABNORMALITIES OF THE CIRCULATION TO THE LIMBS IN THYROTOXICOSIS. , 1965, The Journal of clinical investigation.

[55]  P. Trzepacz,et al.  Hyperthyroid myopathy and the response to treatment. , 1991, Thyroid : official journal of the American Thyroid Association.

[56]  F. Bogazzi,et al.  Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. , 1996, The Journal of clinical endocrinology and metabolism.

[57]  N. Ishikawa,et al.  Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation. , 2000, European heart journal.

[58]  P. Sótonyi,et al.  Cardiac nuclear hormone receptor mRNA in heart failure in man. , 1996, Life sciences.

[59]  K. Harjai,et al.  Effects of Amiodarone on Thyroid Function , 1997, Annals of Internal Medicine.

[60]  S. Liggett,et al.  Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons. , 1997, Circulation.

[61]  T. Parkin,et al.  Treatment of heart disease associated with myxedema. , 1961, Progress in cardiovascular diseases.

[62]  R. Mainwaring,et al.  Reduction in Triiodothyronine Levels Following Modified Fontan Procedure , 1994, Journal of cardiac surgery.

[63]  K. Ojamaa,et al.  Alterations in cardiac contractility and gene expression during low-T3 syndrome: prevention with T3. , 1997, American journal of physiology. Endocrinology and metabolism.

[64]  Robert W. Anderson,et al.  Cardiovascular Effects of Intravenous Triiodothyronine in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Randomized, Double-blind, Placebo-Controlled Trial , 1996 .

[65]  W F Bluhm,et al.  Overexpression of sarcoplasmic reticulum Ca(2+)-ATPase improves cardiac contractile function in hypothyroid mice. , 1999, Cardiovascular research.

[66]  Jennifer D. Walker,et al.  The novel effects of 3,5,3'-triiodo-L-thyronine on myocyte contractile function and beta-adrenergic responsiveness in dilated cardiomyopathy. , 1994, The Journal of thoracic and cardiovascular surgery.

[67]  S. Thomas,et al.  Thyroid hormone treatment after coronary-artery bypass surgery. , 1995, The New England journal of medicine.

[68]  R. Mainwaring,et al.  Pharmacokinetic evaluation of triiodothyronine supplementation in children after modified Fontan procedure. , 2000, Circulation.

[69]  I. Klein,et al.  Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. , 1990, The American journal of medicine.

[70]  I. Klein,et al.  Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. , 2000, Endocrinology.

[71]  E. O. Theilen,et al.  Hemodynamic effects of peripheral vasoconstriction in normal and thyrotoxic subjects. , 1967, Journal of applied physiology.

[72]  F. Ismail-Beigi,et al.  Thyroidal enhancement of rat myocardial Na,K-ATPase: Preferential expression of α2 activity and mRNA abundance , 1990, The Journal of Membrane Biology.

[73]  E W Bough,et al.  Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. , 1977, The New England journal of medicine.

[74]  M. Bettendorf,et al.  Transient Secondary Hypothyroidism in Children after Cardiac Surgery , 1997, Pediatric Research.

[75]  I. Klein,et al.  Time course of the in vivo effects of thyroid hormone on cardiac gene expression. , 1992, Endocrinology.

[76]  S. Wieshammer,et al.  Acute hypothyroidism slows the rate of left ventricular diastolic relaxation. , 1989, Canadian journal of physiology and pharmacology.

[77]  W. White,et al.  Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo- controlled trial. Duke T3 study group. , 1996, JAMA.

[78]  G. Kahaly,et al.  Cardiovascular hemodynamics and exercise tolerance in thyroid disease. , 2002, Thyroid : official journal of the American Thyroid Association.

[79]  A. Samarel,et al.  Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart. , 1996, Endocrinology.

[80]  I. Grupp,et al.  Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts. , 1998, Circulation research.

[81]  T. Feldman,et al.  Myocardial mechanics in hyperthyroidism: importance of left ventricular loading conditions, heart rate and contractile state. , 1986, Journal of the American College of Cardiology.

[82]  J. Franklyn,et al.  Mortality after the treatment of hyperthyroidism with radioactive iodine. , 1998, The New England journal of medicine.

[83]  I. Klein,et al.  Beta-Adrenergic Receptor Blocking Drugs in the Management of Hyperthyroidism , 1994 .

[84]  G. Sandler,et al.  The nature and prognosis of heart disease in thyrotoxicosis. A review of 150 patients treated with 131 I. , 1959, The Quarterly journal of medicine.

[85]  I. Klein,et al.  Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. , 1986, The Journal of clinical investigation.

[86]  H. Nakazawa,et al.  Hyperthyroidism and the management of atrial fibrillation. , 2002, Thyroid : official journal of the American Thyroid Association.

[87]  J. Amico,et al.  Clinical and chemical assessment of thyroid function during therapy with amiodarone. , 1984, Archives of internal medicine.

[88]  P. Ladenson,et al.  Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[89]  K. Ito,et al.  Management of atrial fibrillation in the post-thyrotoxic state. , 1982, The American journal of medicine.

[90]  W. Dillmann.  Biochemical basis of thyroid hormone action in the heart. , 1990, The American journal of medicine.

[91]  G. Rosenthal,et al.  Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease. , 2000, Journal of Thoracic and Cardiovascular Surgery.

[92]  How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. , 1996 .

[93]  F. Sellke,et al.  The Direct Vasomotor Effect of Thyroid Hormones on Rat Skeletal Muscle Resistance Arteries , 1997, Anesthesia and analgesia.

[94]  L. J. Groot,et al.  Dangerous Dogmas in Medicine: The Nonthyroidal Illness Syndrome , 1999 .

[95]  M. Bettendorf,et al.  Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study , 2000, The Lancet.

[96]  S. Connolly,et al.  How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. , 1996, Archives of internal medicine.

[97]  J. Laragh,et al.  PLasma renin activity in syndromes of thyroid hormone excess and deficiency. , 1982, Life sciences.

[98]  J. Campbell,et al.  A correlation of clinical and hemodynamic studies in patients with hyperthyroidism with and without congestive heart failure. , 1959, The Journal of clinical investigation.